With healthcare workers and their loved ones at risk, provider organizations are looking for ways to leverage technology to keep their workers healthy while continuing to deliver essential healthcare services in their communities. Increasingly, they are looking in a familiar place—remote patient monitoring—but with a twist. Now, in some cases, those patients are also employees.
On episode 8 of PSQH: The Podcast, host Jay Kumar talks to Tom Knight, CEO of Invistics, about drug diversion and the impact it has on hospitals.
CMS said it will use existing evaluation and management payment codes to reimburse providers who are eligible to bill CMS for counseling services regardless of the testing venue, including doctors’ offices, urgent care clinics, hospitals and community drive-thru or pharmacy testing sites.
The waivers modify or temporarily suspend certain CMS and HHS regulatory requirements as long as the PHE is ongoing. Hospitals, for instance, have used the blanket waivers to expand the use of telehealth, delay some testing and maintenance of non-critical systems, and use temporary facilities as ways to ease the financial and daily burden of meeting the surge of COVID-19 patients.
During the COVID-19 pandemic, patients have been reluctant to visit healthcare facilities due to concerns over coronavirus infection. In April, a Medical Group Management Association survey found that physician practices had experienced a 60% average decrease in patient volume.
Joseph P. Iannotti, MD, PhD, interim CEO & president, and chief of staff of Cleveland Clinic Florida, talked to HealthLeaders about the role of this type of virus research and why therapeutic innovations are essential to improve the future of healthcare.
The LocumTenens.com survey was conducted in June and highlights information collected from 940 healthcare professionals in 35 medical specialties.
The COVID-19 pandemic has made patients hesitant about visiting doctor offices due to fear of infection. In April, a Medical Group Management Association survey found that physician practices had experienced 60% average decrease in patient volume.
The test, which detects stomach, esophageal, colorectal, lung and liver cancer, also found cancer in 88% of samples from 113 patients who were already diagnosed when the samples were collected, and recognized cancer-free samples 95% of the time, according to the study, which was published this week in Nature Communications.
UCLA researchers wrote that a small study of 34 patients, with a median age of 43, found that the antibodies against SARS-CoV-2 — the virus that causes the disease — decreased by roughly half every 73 days, and would disappear entirely within a year at such a rate.